Insight Molecular Diagnostics's total assets for Q2 2025 were $50.52M, a decrease of -16.31% from the previous quarter. IMDX total liabilities were $49.42M for the fiscal quarter, a -1.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.